SMYD3 and breast cancer: More importantly, SMYD3 activates the AKT signaling through inducing IGF-1R expression; while AKT stimulated SMYD3 expression in an E2F-1-dependent manner, thus forming a positive feedback circuit leading to the hyperactivated AKT signaling in BC cells.